Company Overview of Tekla Life Sciences Investors
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as strong market position for services or products, experienced business management, recognized technological expertise,...
2 Liberty Square
Boston, MA 02109
Founded in 1992
Key Executives for Tekla Life Sciences Investors
Principal Executive Officer, President, Trustee and Member of Valuation Committee
Principal Financial Officer, Chief Compliance Officer, Secretary and Treasurer
Compensation as of Fiscal Year 2014.
Tekla Life Sciences Investors Key Developments
Tekla Life Sciences Investors Declares a Stock Distribution, Payable on March 31, 2015
Feb 20 15
On February 20, 2015, Tekla Life Sciences Investors declared a stock distribution of $0.50 per share. The record date for the stock distribution is March 2, 2015 and the payable date is March 31, 2015. The Fund will trade ex-distribution on February 26, 2015.
H&Q Life Sciences Investors has Changed its Name to Tekla Life Sciences Investors
Oct 15 14
H&Q Life Sciences Investors changed its name to Tekla Life Sciences Investors.
H&Q Life Sciences Investors, Annual General Meeting, Jun 09, 2014
May 22 14
H&Q Life Sciences Investors, Annual General Meeting, Jun 09, 2014., at 08:30 US Eastern Standard Time. Location: Downtown Harvard Club of Boston, One Federal Street. Agenda: To consider the election of Trustees of the Fund; and to approve the ratification or rejection of the selection of Deloitte & Touche LLP as the independent registered public accountants of the fund for the fiscal year ending September 30, 2014; and to approve the transaction of such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
Similar Private Companies By Industry
Recent Private Companies Transactions